Voluntary Medical Male Circumcision: an Introduction to the Cost, Impact, and Challenges of Accelerated Scaling Up

Overview

Journal PLoS Med

Specialty General Medicine

Date 2011 Dec 6

PMID 22140362

Citations 42

Authors

Catherine Hankins

Steven Forsythe

Emmanuel Njeuhmeli

Affiliations

Soon will be listed here.

Abstract

Scaling up voluntary medical male circumcision (VMMC) for HIV prevention is cost saving and creates fiscal space in the future that otherwise would have been encumbered by antiretroviral treatment costs. An investment of US$1,500,000,000 between 2011 and 2015 to achieve 80% coverage in 13 priority countries in southern and eastern Africa will result in net savings of US$16,500,000,000. Strong political leadership, country ownership, and stakeholder engagement, along with effective demand creation, community mobilisation, and human resource deployment, are essential. This collection of articles on determining the cost and impact of VMMC for HIV prevention signposts the way forward to scaling up VMMC service delivery safely and efficiently to reap individual- and population-level benefits.

Citing Articles

Shifting reasons for older men remaining uncircumcised: Findings from a pre- and post-demand creation intervention among men aged 25-39 years in western Kenya.

Agot K, Onyango J, Otieno G, Musingila P, Gachau S, Ochillo M PLOS Glob Public Health. 2024; 4(5):e0003188.

PMID: 38820408 PMC: 11142559. DOI: 10.1371/journal.pgph.0003188.

Relative efficiency of demand creation strategies to increase voluntary medical male circumcision uptake: a study conducted as part of a randomised controlled trial in Zimbabwe.

Mangenah C, Mavhu W, Garcia D, Gavi C, Mleya P, Chiwawa P BMJ Glob Health. 2021; 6(Suppl 4).

PMID: 34275870 PMC: 8287601. DOI: 10.1136/bmjgh-2021-004983.

Association between medical male circumcision and HIV risk compensation among heterosexual men: a systematic review and meta-analysis.

Gao Y, Yuan T, Zhan Y, Qian H, Sun Y, Zheng W Lancet Glob Health. 2021; 9(7):e932-e941.

PMID: 33939956 PMC: 8690595. DOI: 10.1016/S2214-109X(21)00102-9.

Priority Setting in HIV, Tuberculosis, and Malaria - New Cost-Effectiveness Results From WHO-CHOICE.

Ralaidovy A, Lauer J, Pretorius C, Briet O, Patouillard E Int J Health Policy Manag. 2021; 10(11):678-696.

PMID: 33590743 PMC: 9278379. DOI: 10.34172/ijhpm.2020.251.

Healthcare workers' perceptions and experiences of implementing voluntary medical male circumcision in KwaZulu-Natal, South Africa.

Nxumalo C, Mchunu G Afr J Prim Health Care Fam Med. 2020; 12(1):e1-e10.

PMID: 32242429 PMC: 7160602. DOI: 10.4102/phcfm.v12i1.2253.

References

Thomas A, Tran B, Cranston M, Brown M, Kumar R, Tlelai M . Voluntary medical male circumcision: a cross-sectional study comparing circumcision self-report and physical examination findings in Lesotho. PLoS One. 2011; 6(11):e27561. PMC: 3226626. DOI: 10.1371/journal.pone.0027561. View

Lagarde E, Dirk T, Puren A, Bertran A . Acceptability of male circumcision as a tool for preventing HIV infection in a highly infected community in South Africa. AIDS. 2002; 17(1):89-95. DOI: 10.1097/00002030-200301030-00012. View

Tobian A, Serwadda D, Quinn T, Kigozi G, Gravitt P, Laeyendecker O . Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med. 2009; 360(13):1298-309. PMC: 2676895. DOI: 10.1056/NEJMoa0802556. View

Edgil D, Stankard P, Forsythe S, Rech D, Chrouser K, Adamu T . Voluntary medical male circumcision: logistics, commodities, and waste management requirements for scale-up of services. PLoS Med. 2011; 8(11):e1001128. PMC: 3226460. DOI: 10.1371/journal.pmed.1001128. View

Halperin D, Fritz K, McFarland W, Woelk G . Acceptability of adult male circumcision for sexually transmitted disease and HIV prevention in Zimbabwe. Sex Transm Dis. 2005; 32(4):238-9. DOI: 10.1097/01.olq.0000149782.47456.5b. View

Curran K, Njeuhmeli E, Mirelman A, Dickson K, Adamu T, Cherutich P . Voluntary medical male circumcision: strategies for meeting the human resource needs of scale-up in southern and eastern Africa. PLoS Med. 2011; 8(11):e1001129. PMC: 3226463. DOI: 10.1371/journal.pmed.1001129. View

H Gray R, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F . Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007; 369(9562):657-66. DOI: 10.1016/S0140-6736(07)60313-4. View

Weiss H, Dickson K, Agot K, Hankins C . Male circumcision for HIV prevention: current research and programmatic issues. AIDS. 2010; 24 Suppl 4:S61-9. PMC: 4233247. DOI: 10.1097/01.aids.0000390708.66136.f4. View

Cohen M, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N . Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365(6):493-505. PMC: 3200068. DOI: 10.1056/NEJMoa1105243. View

10.

Musau P, Demirelli M, Muraguri N, Ndwiga F, Wainaina D, Ali N . The safety profile and acceptability of a disposable male circumcision device in Kenyan men undergoing voluntary medical male circumcision. J Urol. 2011; 186(5):1923-7. DOI: 10.1016/j.juro.2011.07.027. View

11.

Bailey R, Moses S, Parker C, Agot K, Maclean I, Krieger J . Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007; 369(9562):643-56. DOI: 10.1016/S0140-6736(07)60312-2. View

12.

Mahler H, Kileo B, Curran K, Plotkin M, Adamu T, Hellar A . Voluntary medical male circumcision: matching demand and supply with quality and efficiency in a high-volume campaign in Iringa Region, Tanzania. PLoS Med. 2011; 8(11):e1001131. PMC: 3226544. DOI: 10.1371/journal.pmed.1001131. View

13.

Westercamp N, Bailey R . Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a review. AIDS Behav. 2006; 11(3):341-55. PMC: 1847541. DOI: 10.1007/s10461-006-9169-4. View

14.

. Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making?. PLoS Med. 2009; 6(9):e1000109. PMC: 2731851. DOI: 10.1371/journal.pmed.1000109. View

15.

Nasio J, Nagelkerke N, Mwatha A, Moses S, Ndinya-Achola J, Plummer F . Genital ulcer disease among STD clinic attenders in Nairobi: association with HIV-1 and circumcision status. Int J STD AIDS. 1996; 7(6):410-4. DOI: 10.1258/0956462961918374. View

16.

Bertrand J, Njeuhmeli E, Forsythe S, Mattison S, Mahler H, Hankins C . Voluntary medical male circumcision: a qualitative study exploring the challenges of costing demand creation in eastern and southern Africa. PLoS One. 2011; 6(11):e27562. PMC: 3226625. DOI: 10.1371/journal.pone.0027562. View

17.

Hankins C, de Zalduondo B . Combination prevention: a deeper understanding of effective HIV prevention. AIDS. 2010; 24 Suppl 4:S70-80. DOI: 10.1097/01.aids.0000390709.04255.fd. View

18.

Kebaabetswe P, Lockman S, Mogwe S, Mandevu R, Thior I, Essex M . Male circumcision: an acceptable strategy for HIV prevention in Botswana. Sex Transm Infect. 2003; 79(3):214-9. PMC: 1744675. DOI: 10.1136/sti.79.3.214. View

19.

Morris B, H Gray R, Castellsague X, Bosch F, Halperin D, Waskett J . The Strong Protective Effect of Circumcision against Cancer of the Penis. Adv Urol. 2011; 2011:812368. PMC: 3113366. DOI: 10.1155/2011/812368. View

20.

Weiss H, Halperin D, Bailey R, Hayes R, Schmid G, Hankins C . Male circumcision for HIV prevention: from evidence to action?. AIDS. 2008; 22(5):567-74. DOI: 10.1097/QAD.0b013e3282f3f406. View